Frye received grant support from Assurex Health, Baszucki Group, Myriad, Mayo Foundation and BD2, received CME travel and honoraria from Carnot Laboratories and American Physician Institute and has Financial Interest/Stock ownership/Royalties from Chymia LLC
Insulin and insulin secretagogues - adding tirzepatide to insulin or insulin secretagogues (e.g., sulfonylureas, meglitinides) increases the risk of hypoglycemia
Together, these create a comprehensive support routine for anyone using GLP-1 receptor agonists such as Ozempic, Wegovy, or Mounjaro, helping you stay strong, nourished, and energised throughout your health journey
In most developed countries the disorder can be diagnosed by SeHCAT, in which the 7-day retention of orally administered 75-selenium homocholic acid taurine is measured with a gamma camera